These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10876850)

  • 1. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis].
    Popov OV; Sumarokov AA; Shkol'nik RIa; El'bert LB; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):34-9. PubMed ID: 3898672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new prospective vaccine against tick-borne encephalitis].
    Chumakov MP; Rubin SG; Semashko IV; Karavanov AS; Avdeeva LI; Gagarina AV; Gambarian AS; Matrosovich MN; Mart'ianova LI; Mironova LL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):36-40. PubMed ID: 1858468
    [No Abstract]   [Full Text] [Related]  

  • 5. [An assessment of the immunoepidemiological efficacy of a liquid cultured killed vaccine against tick-borne encephalitis virus strain 205 in the Maritime Territory].
    Leonova GN; Liubimova NB; Sergeev GA; Muratkina SM; Krugliak SP; Bobkov AV; Bondarenko SI; Tutubalina GN; Beliaev MM
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):43-6. PubMed ID: 1441813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-immunological study of the effectiveness of vaccination against tick-borne encephalitis in the Maritime Territory].
    Leonova GN; Krugliak SP; Stepanova NM; Gorelikov VN
    Vopr Virusol; 1987; 32(2):225-8. PubMed ID: 3604187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
    Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
    J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis.
    Stephenson JR; Lee JM; Easterbrook LM; Timofeev AV; Elbert LB
    Vaccine; 1995; 13(8):743-6. PubMed ID: 7483789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human.
    Leonova GN; Pavlenko EV
    Vaccine; 2009 May; 27(21):2899-904. PubMed ID: 19366574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Persistence of the tick-borne encephalitis virus in the vaccinated organism].
    Levina LS; Pogodina VV
    Vopr Virusol; 1988; 33(4):485-90. PubMed ID: 3195146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience in implementing the mass immunization program against tick-borne encephalitis in the Sverdlovsk Region].
    Romanenko VV; Esiunina MS; Kiliachina AS
    Vopr Virusol; 2007; 52(6):22-5. PubMed ID: 18050713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study.
    Bock HL; Klockmann U; Jüngst C; Schindel-Künzel F; Theobald K; Zerban R
    Vaccine; 1990 Feb; 8(1):22-4. PubMed ID: 2316281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possible use of a concentrated vaccine against tick-borne encephalitis for immunizing donors to obtain specific immunoglobulin].
    Subbotina LS; Beliavskaia NA; Matiukhina LV; Kopylova LM; Kul'chitskaia TI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Sep; (9):71-4. PubMed ID: 6506942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of vaccination and serotherapy in tick-borne encephalitis in the Maritime Territory].
    Leonova GN
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Oct; (10):59-64. PubMed ID: 2609812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis].
    Vorob'eva MS; El'bert LB; Grachev VP; Lelikov VL; Pervikov IuV
    Vopr Virusol; 1983; 28(5):622-6. PubMed ID: 6659477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
    Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
    Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.